Description

BACKGROUND: The field of cancer genomics has rapidly adopted next-generation sequencing (NGS) in order to study and characterize malignant tumors with unprecedented resolution. In particular for cancer, one is often

BACKGROUND: The field of cancer genomics has rapidly adopted next-generation sequencing (NGS) in order to study and characterize malignant tumors with unprecedented resolution. In particular for cancer, one is often trying to identify somatic mutations--changes specific to a tumor and not within an individual's germline. However, false positive and false negative detections often result from lack of sufficient variant evidence, contamination of the biopsy by stromal tissue, sequencing errors, and the erroneous classification of germline variation as tumor-specific.

Reuse Permissions
  • application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2013-05-04
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1186/1471-2164-14-302
    • Identifier Type
      International standard serial number
      Identifier Value
      1471-2164

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Christoforides, A., Carpten, J. D., Weiss, G. J., Demeure, M. J., Von Hoff, D. D., & Craig, D. W. (2013). Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC Genomics, 14(1), 302. doi:10.1186/1471-2164-14-302

    Machine-readable links